Quantcast

Posts related to ‘ALKS’

The Unusual Suspects (AMLN, LLY, ALKS, ESLR, ENER, DPS, ATHN, SQNM, ABK, NKE, FDX, GME, COMS, PALM)

Posted: March 14, 2010 at 7:41 am

This week we have several issues to watch.  Earnings season is mostly done but there are still many on deck in this week's unusual suspects.  Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN), ...
Read Full Story »

The Unusual Suspects (HRB, TIVO, AAPL, AMLN, LLY, ALKS, PCX, BCE, MBT, QCOM, ZANE)

Posted: March 7, 2010 at 10:13 am

This week's list of UNUSUAL SUSPECTS for stocks to watch is actually much different from what we have seen in other reports.  Earnings season is finally over, so we only ...
Read Full Story »

Top Analyst Downgrades (ALKS, JTX, MPW, NFG)

Posted: August 27, 2009 at 8:14 am

It is fairly light out in there in realm of analyst downgrades this morning.  These are this Thursday's top analyst downgrades or cautious calls from Wall Street this morning: Alkermes ...
Read Full Story »

Top Day Trader Alerts (ALKS, LLY, SNY, MRK, SPPI, LXK, BSX, JDAS, IDIX, PKG, CVBF, WERN)

Posted: July 21, 2009 at 7:40 am

These are some of this morning's top stocks to watch for active trading today based on pre-market and after-hours volume activity. There are links through to more detailed coverage and ...
Read Full Story »

BioHealth Business Daily (AMGN, NVS, AMLN, LLY, ALKS, NVO, LLY, VICL, SCLN, ARNA)

Posted: July 8, 2009 at 9:47 am

These are some of the top stories affecting key drug and biotech stocks that are covered with more in-depth details and analysis this morning at BioHealthInvestor.com: Amgen Inc’s (Nasdaq: AMGN)’s ...
Read Full Story »

Diabetes Trifecta (AMLN, LLY, ALKS)

Posted: December 11, 2008 at 10:10 am

Amylin Pharmaceuticals, Inc., (NASDAQ: AMLN) has been a battered biotech lately.  But shares have just now gotten back above the single-digit threshold and are up more than 80% from recent ...
Read Full Story »

Biotech Busine$$ Daily (ALKS, CADX, CVTX, MNKD, GNBT, PPHM)

Posted: April 14, 2008 at 12:16 pm

Alkermes (NASDAQ: ALKS) and Johnson & Johnson Pharmaceutical Research and Developed today submitted paperwork seeking approval of their partnership drug, RISPERDAL CONSTA, to be allowed for treatment of bipolar disorder ...
Read Full Story »

Top 10 Pre-Market Analyst Calls (ABH, ALKS, AMAT, DEO, EBAY, KNXA, MMM, PWAV, TKC, NRG, EIX, ETR)

Posted: November 9, 2007 at 8:00 am

Credit Suisse downgraded key power stocks: NRG Energy (NRG), Edison(EIX), and Entergy (ETR) all downgraded to Neutral on valuation afterlarge runs.The top 10 individual analysts calls 24/7 Wall St. is ...
Read Full Story »